| Chr | chr7 |
| start | 79452877 |
| end | 79471208 |
| lncRNA name | MAGI2-AS3 |
| entrez id | 100505881 |
| hgnc id | HGNC:40862 |
| ensg id | ENSG00000234456 |
| refseq id | NR_038343 |
| methods | qPCR, Western blot etc. |
| regulated | down-regulated |
| function description | Our results showed MAGI2-AS3 to be down-regulated in breast cancer tissues compared to normal adjacent tissues. Moreover, MAGI2-AS3 markedly inhibited breast cancer cell growth and increased expression of Fas and Fas ligand (FasL). In conclusion, our data suggest that MAGI2-AS3 expression is decreased in breast cancer and that MAGI2-AS3 plays an important role as a tumour suppressor by targeting Fas and FasL signalling. |
| pubmed id | 29679339 |
| year | 2018 |
| title | Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway. |
| drug | X |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China